ADARx Pharmaceuticals, Inc. is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. The Company is focused on advancing and expanding its pipeline of highly potent, selective and durable siRNA therapeutic candidates, including three clinical-stage programs and two advanced preclinical programs. siRNA, or small interfering RNA, therapeutics represent a significant advancement in precision medicine by addressing diseases at the genetic level (mRNA or RNA) while avoiding permanent alterations to a patient’s genome (DNA). Its hepatic-targeted programs include Agazisiran, Onvuzosiran, and ADX-626. Its extrahepatic-targeted programs include ADX-077 and ADX-199. ADX-077 is designed to reduce body weight and fat while preserving lean mass. ADX-626, is in development for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| ADRX | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| ADRX | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
ADARx Pharmaceuticals, Inc. (ADRX) share price today is $0
Yes, Indians can buy shares of ADARx Pharmaceuticals, Inc. (ADRX) on Vested. To buy
Yes, you can purchase fractional shares of ADARx Pharmaceuticals, Inc. (ADRX) via the Vested app. You can start investing in ADARx Pharmaceuticals, Inc. (ADRX) with a minimum investment of $1.
You can invest in shares of ADARx Pharmaceuticals, Inc. (ADRX) via Vested in three simple steps:
The 52-week high price of ADARx Pharmaceuticals, Inc. (ADRX) is $. The 52-week low price of ADARx Pharmaceuticals, Inc. (ADRX) is $.
The price-to-earnings (P/E) ratio of ADARx Pharmaceuticals, Inc. (ADRX) is
The price-to-book (P/B) ratio of ADARx Pharmaceuticals, Inc. (ADRX) is 0.00
The dividend yield of ADARx Pharmaceuticals, Inc. (ADRX) is 0.00%
The market capitalization of ADARx Pharmaceuticals, Inc. (ADRX) is
The stock symbol (or ticker) of ADARx Pharmaceuticals, Inc. is ADRX
Consider the share price of ADARx Pharmaceuticals, Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether ADARx Pharmaceuticals, Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in ADARx Pharmaceuticals, Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the ADARx Pharmaceuticals, Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of ADARx Pharmaceuticals, Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that ADARx Pharmaceuticals, Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied
